D-0507-2025 Class II Ongoing
FDA drug recall D-0507-2025 was initiated by The Harvard Drug Group LLC on June 19, 2025 and is designated Class II. Reason for recall: Defective container; blister packaging inadequately sealed. The recall status is ongoing. Affected quantity: 23,232 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- July 9, 2025
- Initiation Date
- June 19, 2025
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 23,232 cartons
Product Description
Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, NDC 0904-6665-61
Reason for Recall
Defective container; blister packaging inadequately sealed.
Distribution Pattern
Nationwide
Code Information
Lot# M05205, Exp Date 10/2026